Thibault, Céline <br/><br/>
Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and Children.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  11 2019 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.01260-19  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--adverse effects<br/>Child<br/>Child, Preschool<br/>Cross Infection--drug therapy<br/>Female<br/>Humans<br/>Infant<br/>Male<br/>Microbial Sensitivity Tests--methods<br/>Piperacillin--adverse effects<br/>Piperacillin, Tazobactam Drug Combination--adverse effects<br/>Prospective Studies<br/>Pseudomonas Infections--drug therapy<br/>Pseudomonas aeruginosa--drug effects<br/>Tazobactam--adverse effects